These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32059638)
1. Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathway. Wang H; Zhong L; Mi S; Song N; Zhang W; Zhong M BMC Cardiovasc Disord; 2020 Feb; 20(1):81. PubMed ID: 32059638 [TBL] [Abstract][Full Text] [Related]
2. The microvesicle/CD36 complex triggers a prothrombotic phenotype in patients with non-valvular atrial fibrillation. Wang H; Song NP; Li JP; Wang ZH; Ti Y; Li YH; Zhang W; Zhong M J Cell Mol Med; 2020 Jul; 24(13):7331-7340. PubMed ID: 32510852 [TBL] [Abstract][Full Text] [Related]
3. Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress. Wang H; Wang ZH; Kong J; Yang MY; Jiang GH; Wang XP; Zhong M; Zhang Y; Deng JT; Zhang W Mol Med; 2012 Mar; 18(1):159-66. PubMed ID: 22064971 [TBL] [Abstract][Full Text] [Related]
4. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Chen K; Febbraio M; Li W; Silverstein RL Circ Res; 2008 Jun; 102(12):1512-9. PubMed ID: 18497330 [TBL] [Abstract][Full Text] [Related]
5. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36. Qi Z; Hu L; Zhang J; Yang W; Liu X; Jia D; Yao Z; Chang L; Pan G; Zhong H; Luo X; Yao K; Sun A; Qian J; Ding Z; Ge J Circulation; 2021 Jan; 143(1):45-61. PubMed ID: 32988222 [TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway. Maione F; De Feo V; Caiazzo E; De Martino L; Cicala C; Mascolo N J Ethnopharmacol; 2014 Sep; 155(2):1236-42. PubMed ID: 25038434 [TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade. Roberts W; Magwenzi S; Aburima A; Naseem KM Blood; 2010 Nov; 116(20):4297-306. PubMed ID: 20664056 [TBL] [Abstract][Full Text] [Related]
9. Effects of tanshinone IIA, a major component of Salvia miltiorrhiza, on platelet aggregation in healthy newborn piglets. Liu JQ; Lee TF; Miedzyblocki M; Chan GC; Bigam DL; Cheung PY J Ethnopharmacol; 2011 Sep; 137(1):44-9. PubMed ID: 21453766 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases. Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207 [TBL] [Abstract][Full Text] [Related]
12. Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome. Fan GQ; Qin RR; Li YH; Song DJ; Chen TS; Zhang W; Zhong M; Zhang Y; Xing YQ; Wang ZH Oncotarget; 2016 Dec; 7(50):83231-83240. PubMed ID: 27825126 [TBL] [Abstract][Full Text] [Related]
13. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein. Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539 [TBL] [Abstract][Full Text] [Related]
14. Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y Chyrchel B; Drożdż A; Długosz D; Stępień EŁ; Surdacki A Int J Med Sci; 2019; 16(2):264-275. PubMed ID: 30745807 [No Abstract] [Full Text] [Related]
15. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling. Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296 [TBL] [Abstract][Full Text] [Related]
16. Qilong capsule prevents myocardial ischemia/reperfusion injury by inhibiting platelet activation via the platelet CD36 signaling pathway. Wang M; Li L; Tang S; Liu J; Liu S; Ye J; Ding G; Sun G J Ethnopharmacol; 2024 Aug; 330():118211. PubMed ID: 38636580 [TBL] [Abstract][Full Text] [Related]
17. Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome. Kafian S; Mobarrez F; Wallén H; Samad B Platelets; 2015; 26(5):467-73. PubMed ID: 25025694 [TBL] [Abstract][Full Text] [Related]
18. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions. Yang M; Cooley BC; Li W; Chen Y; Vasquez-Vivar J; Scoggins NO; Cameron SJ; Morrell CN; Silverstein RL Blood; 2017 May; 129(21):2917-2927. PubMed ID: 28336528 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of peptide inhibitors derived from the extracellular and intracellular domain of α Gkourogianni AV; Kiouptsi K; Koloka V; Moussis V; Tsikaris V; Bachelot-Loza C; Tsoukatos DC Platelets; 2018 Jan; 29(1):34-40. PubMed ID: 28351192 [TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]